Abiopharma

La France étend laccès national à lAAC pour le botensilimab + balstilimab dAgenus contre le cancer de lovaire et les sarcomes des tissus mous

Francia amplía el acceso nacional a la AAC para el botensilimab + balstilimab de Agenus para el cáncer de ovario y los sarcomas de tejidos blandos

Siokas Grigorios 🟢 acquired 113.2K shares of Cosmos Health Inc. (COSM) at $0.50 Transaction Date: Jan 12, 2026 | Filing ID: 000175

フランス、卵巣がんおよび軟部肉腫を対象に、アジーナスの「ボテンシリマブ＋バルスチリマブ」について国家レベルのAACアクセスを拡大

How AI Is Reshaping Your Website’s Role in the Trust Ecosystem | NRC Health webcast

Frankreich erweitert den nationalen AAC-Zugang für Botensilimab und Balstilimab von Agenus zur Behandlung von Eierstockkrebs und Weichteilsarkomen

Frankrijk breidt nationale AAC-toegang uit voor Agenus botensilimab + balstilimab voor eierstokkanker en wekedelensarcomen

Sono-Tek Corp (SOTK) Files Form 10-Q

(100% Positive) Castle Biosciences Inc (CSTL) Provides Update on opportunities for our core revenue drivers (DecisionDx®-Melanoma

法国扩大Agenus用于治疗卵巢癌和软组织肉瘤的Botensilimab + Balstilimab组合疗法的国家同情用药授权范围

法國擴大Agenus用於治療卵巢癌和軟組織肉瘤的Botensilimab + Balstilimab組合療法的國家同情用藥授權範圍

Feminist Rage in the Local Walmart

XTL Biopharmaceuticals Acquires 85% of NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership

(10% Negative) Fortress Biotech Inc. (FBIOP) Announces Delay in issued Development Timeline Due to Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

Illumina, Inc. - Illumina introduces Billion Cell Atlas to accelerate AI and drug discovery